NCT07381842Not yet recruiting
The Effects of Manual Therapy on the Spatiotemporal Gait Characteristics in Patients With Chronic Obstructive Pulmonary Disease
An Investigation of the Effects of Manual Therapy on the Spatiotemporal Gait Characteristics in Patients With Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov · Last updated 2 Feb 2026
Brief summary (registry, in English)
The primary aim of this study is to investigate the effects of manual therapy on spatiotemporal characteristics of gait and gait variability, functional exercise capacity, and pulmonary function in patients with chronic obstructive pulmonary disease (COPD). The secondary aims of the study are to determine the effects of manual therapy on balance, respiratory muscle strength, quality of life, physical activity, symptom severity, accessory respiratory muscle activation, peripheral muscle strength, chest wall mobility, dysfunctional breathing, pain, and posture.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 13 Jan 2026
- Start date
- 8 Feb 2026
- Primary completion date
- 8 Nov 2026
- Lead sponsor
- Hacettepe University
- Diseases
- COPD
- NCT number
- NCT07381842
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 8 Feb 2026 to the primary completion date, 8 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving long-term oxygen therapy
Other illness
- Presence of additional orthopedic, neuromuscular, neurological, or cardiac conditions that may affect gait and balance
- History of lung cancer, sarcoidosis, tuberculosis, and/or lung surgery
- Presence of musculoskeletal conditions such as fibromyalgia, rheumatoid arthritis, or osteoarthritis
- Presence of a known mental or cognitive impairment
Other
- Use of walking assistive devices
Who the study is looking for
- Age 40 years or older
- Clinically stable for at least the past 4 weeks
- Classified as GOLD stage 1, 2, or 3 according to the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) airflow limitation classification
- Classified as group A, B, or E according to the GOLD ABE assessment tool
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hacettepe University Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.